Surgery Partners, Inc. (SGRY) Q2 2025 Earnings Call Transcript

Surgery Partners, Inc. (NASDAQ:SGRY) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET

Company Participants

David T. Doherty – Executive VP & CFO
J. Eric Evans – CEO & Director

Conference Call Participants

Albert J. William Rice – UBS Investment Bank, Research Division
Andrew Mok – Barclays Bank PLC, Research Division
Benjamin Hendrix – RBC Capital Markets, Research Division
Benjamin Michael Rossi – JPMorgan Chase & Co, Research Division
Benjamin Whitman Mayo – Leerink Partners LLC, Research Division
Brian Gil Tanquilut – Jefferies LLC, Research Division
Joanna Sylvia Gajuk – BofA Securities, Research Division
Sarah Elizabeth James – Cantor Fitzgerald & Co., Research Division
Tao Qiu – Macquarie Research
Zachary Haggerty – Unidentified Company
KeyBanc Capital Markets – Unidentified Company

Operator

Good day, and welcome to the Surgery Partners, Inc. Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.

I would now like to turn the conference over to Dave Doherty, Chief Financial Officer. Please go ahead.

David T. Doherty

Good morning, and thank you for joining Surgery Partners Second Quarter 2025 Earnings Call. I am joined today by Eric Evans, our CEO. During this call, we will make forward-looking statements. There are risk factors that could cause future results to be materially different from these statements that are described in this morning’s press release and the reports we file with the SEC, each of which are available on our corporate website. The company does not undertake any duty to update these forward-looking statements. In addition, we reference certain financial measures that are non-GAAP, which we believe can be useful in evaluating our performance. We reconcile these measures to the most applicable GAAP measure in this morning’s press release. With that, I will turn the call over to Eric. Eric?

J. Eric Evans